Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0SH2X
|
|||
Former ID |
DIB011723
|
|||
Drug Name |
Amocarzine
|
|||
Synonyms |
Phenthiourezine; Thiocarbamazine; CGP-6140; S-80016
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Helminth infection [ICD-11: 1F90.0; ICD-10: A00-B99; ICD-9: 001-139] | Phase 3 | [1] | |
Company |
Novartis AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H21N5O2S
|
|||
Canonical SMILES |
CN1CCN(CC1)C(=S)NC2=CC=C(C=C2)NC3=CC=C(C=C3)[N+](=O)[O-]
|
|||
InChI |
1S/C18H21N5O2S/c1-21-10-12-22(13-11-21)18(26)20-16-4-2-14(3-5-16)19-15-6-8-17(9-7-15)23(24)25/h2-9,19H,10-13H2,1H3,(H,20,26)
|
|||
InChIKey |
UFLRJROFPAGRPN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 36590-19-9
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:38946
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Acetylcholinesterase (AChE) | Target Info | Inhibitor | [2] |
KEGG Pathway | Glycerophospholipid metabolism | |||
Cholinergic synapse | ||||
Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
Nicotinic acetylcholine receptor signaling pathway | ||||
Pathwhiz Pathway | Phospholipid Biosynthesis | |||
Pathway Interaction Database | ATF-2 transcription factor network | |||
WikiPathways | Monoamine Transport | |||
Biogenic Amine Synthesis | ||||
Acetylcholine Synthesis | ||||
Integrated Pancreatic Cancer Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment. Ann Trop Med Parasitol. 1997 Apr;91(3):281-96. | |||
REF 2 | Activity, mechanism of action and pharmacokinetics of 2-tert-butylbenzothiazole and CGP 6140 (amocarzine) antifilarial drugs. Acta Trop. 1992 Aug;51(3-4):195-211. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.